Reuters logo
BRIEF-Sangamo Biosciences changes name to Sangamo Therapeutics
January 6, 2017 / 1:13 PM / a year ago

BRIEF-Sangamo Biosciences changes name to Sangamo Therapeutics

Jan 6 (Reuters) - Sangamo Biosciences Inc :

* Sangamo Biosciences changes name to Sangamo Therapeutics, underscoring focus on clinical development of genomic therapies

* Sangamo Biosciences -in 2017, expect to enroll 4 clinical trials for lead programs developing valuable new therapies for patients living with hemophilia A and B

* Sangamo Biosciences Inc says also work closely with collaborator bioverativ, planned spin-off of Biogen’s hemophilia business Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below